Number of shares and voting rights as at 31/07/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st July.

Read the press release


Invitation to the Ordinary and Extraordinary Shareholders' Meeting of August 20, 2019

Availability of preparatory documents for the Annual General Meeting.

Read the press release (in French)


Conversion of convertible bonds by Zigi Capital

Conversion of convertible bonds by Zigi Capital for a total amount of EUR 2 million.

Read the press release (in French)


Number of shares and voting rights as at 30/06/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 30th June.

Read the press release


Number of shares and voting rights as at 31/05/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 31st May.

Read the press release


Number of shares and voting rights as at 30/04/2019

Europlasma declares the number of voting rights and shares comprising its share capital as at 30th April.

Read the press release


Update on legal proceedings progress

According to the judgment of 25 January 2019 declaring the opening of the insolvency proceedings of Europlasma and the Group companies (see press release of 25/01/2019), the Commercial Court of Mont de Marsan set an observation period of 6 months to implement sustainable industrial projects and safeguard jobs.

Read the press release (in French)


Details concerning BSAR exercise

As part of the ongoing proceedings, Europlasma recalls that the share price as well as BSAR B and C of the Company have been suspended since 20 March 2019.

Read the press release (in French)